Abstract
Breast cancer stem cells are regulated by cell intrinsic pathways as well as by elements in the tumor microenvironment. New evidence suggests that an important interaction between the interleukin (IL)-8 receptor CXCR1/2 and HER2 is involved in this regulation. Simultaneous targeting of these pathways provides a novel therapeutic approach.
Original language | English (US) |
---|---|
Pages (from-to) | 511-513 |
Number of pages | 3 |
Journal | Clinical Cancer Research |
Volume | 19 |
Issue number | 3 |
DOIs | |
State | Published - Feb 1 2013 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research